This Article Full Text Full Text (PDF) Supplementary Data Correction (v67,p5060) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khalkhali-Ellis, Z. Articles by Hendrix, M. J.C. Search for Related Content PubMed PubMed Citation Articles by Khalkhali-Ellis, Z. Articles by Hendrix, M. J.C.

Elucidating the Function of Secreted Maspin: Inhibiting Cathepsin D–Mediated Matrix Degradation

¹ Children's Memorial Research Center and ² Robert H. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine, Chicago, Illinois

Requests for reprints: Zhila Khalkhali-Ellis, Cancer Biology and Epigenomics, Children's Memorial Research Center, 2300 Children's Plaza, Box 222, Chicago, IL 60614-3394. Phone: 773-755-6353; E-mail: zellis{at}childrensmemorial.org.

Cellular interaction with the extracellular milieu plays a significant role in normal biological and pathologic processes. Excessive degradation of basement membrane matrix by proteolytic enzymes is a hallmark of tumor invasion and metastasis, and aspartyl proteinase cathepsin D is implicated as a major contributor to this process. Maspin, a non-inhibitory serpin, plays an important role in mammary gland development and remodeling. Expression of Maspin is decreased in primary tumors and lost in metastatic lesions. Maspin is mostly cytoplasmic and is partially secreted; however, the fate and function of secreted Maspin has remained mostly unexplored. We hypothesized that secreted Maspin is incorporated into the matrix deposited by normal mammary epithelial cells and thus could play a critical role in cathepsin D–mediated matrix degradation and remodeling of mammary tissue. In the absence of Maspin, as is the case with most cancer cells, matrix degradation proceeds unrestricted, thus facilitating the progression to metastasis. To test this, we employed an in vitro model where gels containing both types I and IV collagen were preconditioned with normal mammary epithelial cells to allow the incorporation of secreted Maspin. This conditioned matrix was used to examine cathepsin D–mediated collagen degradation by human breast cancer cell lines. Our results indicate that secretion of Maspin and its deposition into the extracellular milieu play an important role in matrix degradation. In this capacity, Maspin could potentially regulate mammary tissue remodeling occurring under normal and pathologic conditions. In addition, these findings could have a potential effect on future therapeutic intervention strategies for breast cancer. [Cancer Res 2007;67(8):3535–9]

This article has been cited by other articles:

				R. Bass, L. Wagstaff, L. Ravenhill, and V. Ellis Binding of Extracellular Maspin to {beta}1 Integrins Inhibits Vascular Smooth Muscle Cell Migration J. Biol. Chem., October 2, 2009; 284(40): 27712 - 27720. [Abstract] [Full Text] [PDF]

				P. G. W. Gettins and S. T. Olson Exosite Determinants of Serpin Specificity J. Biol. Chem., July 31, 2009; 284(31): 20441 - 20445. [Abstract] [Full Text] [PDF]

				L.-j. Shao, H. Y. Shi, G. Ayala, D. Rowley, and M. Zhang Haploinsufficiency of the Maspin Tumor Suppressor Gene Leads to Hyperplastic Lesions in Prostate Cancer Res., July 1, 2008; 68(13): 5143 - 5151. [Abstract] [Full Text] [PDF]

				Correction: Elucidating the Function of Secreted Maspin Cancer Res., May 15, 2007; 67(10): 5060 - 5060. [Full Text] [PDF]